Related Experiment Video
Updated: Dec 9, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia
Reinaldo Marín1, Delia I Chiarello2, Cilia Abad3
1Center for Biophysics and Biochemistry (CBB), Venezuelan Institute for Scientific Research (IVIC), AP 21827, Caracas 1020A, Venezuela.
Insights
Preeclampsia involves mitochondrial dysfunction, differing between early-onset (eoPE) and late-onset (loPE) forms. This dysfunction causes oxidative stress and impacts placental function, suggesting therapeutic targets for preeclampsia.
Area of Science:
- Obstetrics and Gynecology
- Mitochondrial Biology
- Pathophysiology
Background:
- Preeclampsia is a serious pregnancy syndrome affecting multiple systems, leading to significant maternal and fetal morbidity and mortality.
- It is classified as early-onset preeclampsia (eoPE) or late-onset preeclampsia (loPE) based on gestational age at delivery (before or after 34 weeks).
- Preeclampsia is increasingly recognized as a mitochondrial disorder, but the specific roles of mitochondrial dysfunction in eoPE versus loPE remain unclear.
Purpose of the Study:
- To review and summarize the current understanding of mitochondrial dysfunction in both early-onset preeclampsia (eoPE) and late-onset preeclampsia (loPE).
- To explore the differential involvement of mitochondrial alterations in eoPE and loPE.
- To discuss potential therapeutic strategies targeting mitochondrial dysfunction in preeclampsia.
Main Methods:
- Review of existing literature on mitochondrial structure and function in preeclamptic placentas.
- Analysis of studies investigating molecular mechanisms, including protein expression and mitochondrial dynamics (fusion/fission).
- Examination of evidence related to the electron transport chain, oxidative phosphorylation, and reactive oxygen species (ROS) production.
Main Results:
- Altered mitochondrial structure and function, leading to increased ROS production, oxidative stress, and cell damage, are observed in the syncytiotrophoblast in both eoPE and loPE.
- Mitochondrial dysfunction in eoPE may involve differential expression of proteins like dynamin-related protein 1 and mitofusins compared to loPE.
- Reduced activity of Complex IV and essential electron transport chain proteins leads to impaired oxidative phosphorylation and mitochondrial respiration in preeclamptic placentas.
Conclusions:
- Mitochondrial dysfunction is a key feature of preeclampsia, with distinct molecular and dynamic alterations potentially differentiating eoPE and loPE.
- Impaired placental mitochondrial respiration and increased oxidative stress contribute to preeclampsia pathogenesis.
- Targeting mitochondrial function and enhancing antioxidative capacity, potentially with agents like coenzyme Q10, shows promise as a therapeutic strategy for preeclampsia.
Abstract:
Preeclampsia is a pregnancy-specific syndrome with multisystem involvement which leads to foetal, neonatal, and maternal morbidity and mortality. This syndrome is characterized by the onset of clinical signs and symptoms and delivery before (early-onset preeclampsia, eoPE), or after (late-onset preeclampsia, loPE), the 34 weeks of gestation. Preeclampsia is a mitochondrial disorder where its differential involvement in eoPE and loPE is unclear. Mitochondria regulate cell metabolism and are a significant source of reactive oxygen species (ROS). The syncytiotrophoblast in eoPE and loPE show altered mitochondrial structure and function resulting in ROS overproduction, oxidative stress, and cell damage and death. Mitochondrial dysfunction in eoPE may result from altered expression of several molecules, including dynamin-related protein 1 and mitofusins, compared with loPE where these factors are either reduced or unaltered. Equally, mitochondrial fusion/fission dynamics seem differentially modulated in eoPE and loPE. It is unclear whether the electron transport chain and oxidative phosphorylation are differentially altered in these two subgroups of preeclampsia. However, the activity of complex IV (cytochrome c oxidase) and the expression of essential proteins involved in the electron transport chain are reduced, leading to lower oxidative phosphorylation and mitochondrial respiration in the preeclamptic placenta. Interventional studies in patients with preeclampsia using the coenzyme Q10, a key molecule in the electron transport chain, suggest that agents that increase the antioxidative capacity of the placenta may be protective against preeclampsia development. In this review, the mitochondrial dysfunction in both eoPE and loPE is summarized. Therapeutic approaches are discussed in the context of contributing to the understanding of mitochondrial dysfunction in eoPE and loPE.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Peroxisomes
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Hormonal Regulation